DISCOVER EXPANDED ACCESS PROGRAMS
myTomorrows provides physicians and patients that are excluded from clinical trials access to drugs in development. We focus on disease areas with unmet needs; oncology, neurology, psychiatry and rare diseases.
Expanded Access Programs include treatments for Severe Depression, Primary Liver Cancer (HCC), Chronic Fatigue Syndrome (CFS), Chest Wall Breast Cancer and Peripheral T-cell Lymphoma (Blood Cancer). Sign up at myTomorrows to see all available programs for your country.SEE ALL PROGRAMS
PROVIDING EARLY ACCESS TO THE LATEST DRUGS IN DEVELOPMENT
WHAT WE DO
Identify drug developments. Our physicians and bio-medical specialists identify the latest drug developments from across the globe.
Inform. Physicians and pharmacists can register online and request information about the drugs myTomorrows provides access to.
Facilitate requests. In most countries health authorities must grant permission for treatment with a non-registered drug. myTomorrows facilitates requests for permission for physicians and pharmacists.
WHAT ARE EXPANDED ACCESS PROGRAMS?
Drug development takes about twelve years from discovery to marketing authorization. Drugs that show promising results during clinical development need to be tested in large patient populations before receiving marketing authorization. In many cases patients with high unmet medical needs that are excluded from clinical trials, can’t afford to wait the extra years it takes for a drug to receive such a marketing authorization.
Expanded Access Programs enable physicians and patients who have exhausted other medicinal treatment options to access development stage drugs or drugs that have marketing authorization elsewhere, but not yet in their home country.LEARN MORE...